What are the opening hours?

Monday 9am - 5pm Tuesday 9am - 5pm Wednesday 9am - 5pm Thursday 9am - 5pm Friday 9am - 5pm

Lampgen Clinical Research

Home
United States
Decatur, GA
Lampgen Clinical Research

At Lampgen, we are a dedicated research partner for companies seeking to bring new medical therapies to market.

Lampgen Clinical Research was founded in 2012, a year in which 39 new molecular entities were approved by the FDA’s Center for Drug Evaluation and Research. At this time, over 120,000 studies had been registered on ClinicalTrial.gov, and this number was only increasing as innovation in biotechnology and bioinformatics yielded new potential therapies. With the volume of clinical studies rising, the need for qualified personnel to provide study oversight and experienced clinical sites was growing exponentially. While the volume of clinical trials were trending up during this period, according to the FDA Office of Scientific Investigations, the overall quality of several clinical investigations was not. Between 2009 and 2013, a total of 83 warning letters were issued by the FDA to clinical investigators, institution review boards (IRBs), biopharmaceutical companies, and CROs. Violations included findings such as improper supervision by clinical investigator, failure to obtain informed consent, and failure to properly monitor a clinical investigation. Issues such as these endanger the lives of clinical trials volunteers. Lampgen was founded to achieve a new standard in clinical development and aid companies in quality research. Lampgen’s model was developed from researching the best practices in clinical development at the academic, CRO, and Sponsor level. It was determined that providing companies with rapid access to expert clinical research professionals to provide oversight at sites was one key to quality clinical develoment. Additionally, it was ascertained that developing existing medical practices into viable research site with internal quality assurance was a proactive method of enhancing the integrity of a given trial. Combining these two elements, Lampgen came into existence with the goal of illuminating new pathways to clinical development.

01/17/2022

The Worst of the Omicron Wave Could Still Be Coming - The Atlantic http://ow.ly/T7jm30s7tjS

A long descent from a peak in cases could exact a larger toll than even Omicron’s blistering ascent.

01/17/2022

Experts warn of more COVID-19 variants after Omicron - Axios http://ow.ly/Fznc30s7t9k

Experts are warning that subsequent COVID-19 variants are likely to come after Omicron, AP reports. Why it matters: The warnings come as there's no guarantee that subsequent variants "will cause milder illness or that existing vaccines will work against them," underscoring the need for widespread va...

01/17/2022

The COVID race to watch: vaccines vs. variants - The Wall Street Journal http://ow.ly/n3f930s7rJJ

Omicron won’t be the omega of Covid-19 variants. But global vaccination is the key to making sure the disease becomes endemic—and a lot more manageable.

01/17/2022

The Silent, Vaccinated, Impatient Majority - The Atlantic http://ow.ly/TMt030s7yzv

As patience with the pandemic wanes, leaders in widely vaccinated democracies are deploying a new political strategy.

01/10/2022

Why More Americans Are Saying They’re ‘Vaxxed and Done’ - The Atlantic http://ow.ly/FZoY30s6Pqr

COVID has always divided Americans. The Omicron wave is even dividing the vaccinated.

01/10/2022

Recognizing obesity as a disease is a step toward health equity - STAT http://ow.ly/4fmZ30s6JyN

There is a palpable shift underway as government leaders and others are adopting a mindset about obesity that is informed by science rather than by prejudice.

01/05/2022

Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine | BioNTech http://ow.ly/zk5x30s6gEm

Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over the world Product candidates will be based on BioNTech’s proprietary mRNA technology and on

01/05/2022

2021 drug approvals: In a year dominated by COVID, biopharma managed to deliver 55 new drugs | FiercePharma http://ow.ly/zBhU30s6egp

Each year, many scientists and other experts working in the biopharma industry see years of their work culminate in FDA approvals. With the COVID-19 crisis stretching into its third year, the 2021 batch of new drug approvals clearly demonstrates that the sector has learned how to operate in a pandem...

01/05/2022

The Data Shows Omicron is Milder. How Should That Affect Your Behavior? - The New York Times http://ow.ly/Sso930s6gB9

How should that affect your behavior?

01/04/2022

Omicron Cases Are Hitting Highs, But New Data Puts End in Sight - Bloomberg http://ow.ly/n1PU30s65EM

Data suggest hospitalizations are now decoupled from case numbers, and the variant causes less severe disease

01/04/2022

Opinion | Omicron Variant May End Up Saving Lives - The Wall Street Journal http://ow.ly/HNlr30s64Nj

It’s far less lethal than previous versions, and its fast spread may finally push us to herd immunity.

01/04/2022

Overwhelmed hospitals. Staffing shortages. Businesses closing. Here’s how the Omicron wave is ravaging local communities - CNN http://ow.ly/n3HT30s64N4

Over the weekend, at least five metro Atlanta school districts announced they would shift to remote learning for the first week of the new year as students return to school after a holiday break that saw the Omicron variant spread even further out of control.

01/03/2022

U.S., Europe weigh isolation requirements as Omicron disrupts daily life - The Wall Street Journal https://apple.news/ATfo2pqfbSEecd7SEBJuRow

With infections surging, lengthy quarantine periods threaten the functioning of health systems, other workplaces

01/03/2022

10 lessons I’ve learned from the Covid-19 pandemic - STAT http://ow.ly/W5uK30s5UBw

Some things have gone surprisingly well, notably the rapid development of Covid vaccines and some therapeutics. But far more things have gone horribly wrong.

01/03/2022

Forecasting the Omicron winter: Experts envision various scenarios http://ow.ly/zcE630s5UB6

Some modelers fear Omicron could bring the deadliest phase of the pandemic yet.

01/03/2022

FDA authorizes first COVID-19 booster shot for adolescents aged 12 to 15 - STAT http://ow.ly/awq330s61Qs

The FDA extended the emergency use authorization for the Pfizer and BioNTech Covid-19 booster shot to include teens aged 12 to 15, paving the way for them to be eligible for the jabs later this week.

01/03/2022

K-12 Schools Press to Reopen as Omicron Variant Surges - The Wall Street Journal http://ow.ly/C4WB30s5UlH

K-12 systems nationwide seek Covid-19 tests as Milwaukee decides to start classes remotely

Address

4153 Flat Shoals Road
Decatur, GA
30034

Opening Hours

Monday	9am - 5pm
Tuesday	9am - 5pm
Wednesday	9am - 5pm
Thursday	9am - 5pm
Friday	9am - 5pm

Website

http://LampgenCR.com/

Alerts

Be the first to know and let us send you an email when Lampgen Clinical Research posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Lampgen Clinical Research:

Shortcuts

Want your practice to be the top-listed Clinic in Decatur?

Lampgen Clinical Research

01/17/2022

01/17/2022

01/17/2022

01/17/2022

01/10/2022

01/10/2022

01/05/2022

01/05/2022

01/05/2022

01/04/2022

01/04/2022

01/04/2022

01/03/2022

01/03/2022

01/03/2022

01/03/2022

01/03/2022

Address

Opening Hours

Website

Alerts

Contact The Practice

Shortcuts

Share

Category